NICE says 'not enough data' to approve drug for ovarian cancer
The National Institute for Health and Care Excellence (NICE) says it cannot give a positive decision over whether to recommend a new drug for ovarian cancer unless its makers provide more information on cost. A final decision ...
Aug 7, 2015
0
10